Unit of Vascular Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Aortic Center, CHU Lille, Lille, France.
J Endovasc Ther. 2024 Dec;31(6):1208-1217. doi: 10.1177/15266028231162256. Epub 2023 Mar 28.
This study investigated the long-term outcomes of patients treated with fenestrated and branched endovascular aneurysm repair (F-BEVAR) or open surgical repair (OSR) for complex abdominal aortic aneurysms (c-AAAs). Complex abdominal aortic aneurysms are defined as aneurysms that involve the renal or mesenteric arteries and extend up to the level of the celiac axis or diaphragmatic hiatus but do not extend into the thoracic aorta. This study compares with a propensity-score matching the outcome of these procedures from 2 high-volume aortic centers.
All patients with c-AAAs undergoing repair at 2 centers between January 2010 and June 2016 were included. The long-term imaging follow-up consisted in a yearly computed tomography angiography (CTA) in the F-BEVAR group. Yearly abdominal ultrasound examination and 5-year CTA were performed in the OSR group. The primary endpoints were long-term mortality, aneurysm-related mortality, and chronic renal decline (CRD), defined as estimated glomerular filtration rate reduction to <60 mL/min/1.73 m or >20%/de novo dependence on permanent dialysis in patients with normal or abnormal preoperative renal function, respectively. Secondary endpoints included aortic-related reinterventions, target vessel occlusion, proximal aorta degeneration, access-related complications, graft infection, and the composite endpoint of clinical failure during follow-up.
After 1:1 propensity matching, 102 consecutive patients who underwent F-BEVAR and OSR, respectively, were included. The median follow-up was 67 months. There was no significant difference in long-term overall mortality (40.2% vs 36.3%; p=0.40) and aneurysm-related mortality (6.8% vs 5.8%; p=0.30), in the F-BEVAR and OSR groups, respectively. During follow-up, late renal function decline occurred in 27 (27.8%) versus 46 patients (47.4%) in the F-BEVAR and OSR groups, respectively (p<0.01). During follow-up, 23 reinterventions (23.5%) were performed in the F-BEVAR group, and 5 (5.1%) in the OSR group (p<0.01).
No differences in overall and aneurysm-related mortality were observed. Chronic renal decline was significantly higher after OSR, while the reintervention rate was higher in the F-BEVAR group. These long-term results reflect the outcomes of a complex procedure performed by a single experienced operator in 2 high-volume centers, and followed with a strict surveillance imaging follow-up.
Nowadays, F-BEVAR and OSR are considered two established techniques for the treatment of c-AAA. However, long-term comparative outcomes are not well studied, and concerns may rise in terms of durability of the repair, risk of reinterventions and late chronic renal decline. The present study showed, with a median follow-up > 5 years, no differences in overall and aneurysm-related mortality. Chronic renal decline was significantly higher after OSR, while the reintervention rate was higher in the endovascular group. To achieve the best possible long-term outcomes, both techniques should be performed in high volume aortic centres, tailored to the patient, and with an adequate surveillance imaging.
本研究旨在探讨接受腔内分支型腹主动脉瘤修复术(F-BEVAR)或开放手术修复术(OSR)治疗复杂腹主动脉瘤(c-AAA)患者的长期结局。复杂腹主动脉瘤定义为累及肾或肠系膜动脉且延伸至腹腔干或膈肌裂孔水平但不延伸至胸主动脉的动脉瘤。本研究通过倾向评分匹配比较了这两种手术在 2 个高容量主动脉中心的结果。
纳入 2010 年 1 月至 2016 年 6 月期间在 2 个中心接受 c-AAA 修复的所有患者。F-BEVAR 组的长期影像学随访包括每年进行一次计算机断层血管造影(CTA)。OSR 组每年进行腹部超声检查和 5 年 CTA。主要终点是长期死亡率、动脉瘤相关死亡率和慢性肾功能下降(CRD),定义为术前肾功能正常或异常的患者肾小球滤过率降低至<60ml/min/1.73m2 或>20%/新依赖永久性透析。次要终点包括主动脉相关再次介入、靶血管闭塞、近端主动脉退变、入路相关并发症、移植物感染和随访期间的临床失败复合终点。
1:1 倾向评分匹配后,分别纳入 102 例连续接受 F-BEVAR 和 OSR 的患者。中位随访时间为 67 个月。F-BEVAR 和 OSR 组的长期总体死亡率(40.2%vs.36.3%;p=0.40)和动脉瘤相关死亡率(6.8%vs.5.8%;p=0.30)无显著差异。在随访期间,F-BEVAR 和 OSR 组分别有 27(27.8%)和 46 例(47.4%)患者发生晚期肾功能下降(p<0.01)。在随访期间,F-BEVAR 组进行了 23 次(23.5%)再次介入,OSR 组进行了 5 次(5.1%)再次介入(p<0.01)。
两组总体死亡率和动脉瘤相关死亡率无差异。OSR 后慢性肾功能下降显著升高,而 F-BEVAR 组的再介入率较高。这些长期结果反映了在 2 个高容量中心由经验丰富的单一术者进行的复杂手术的结果,并进行了严格的监测影像学随访。
目前,F-BEVAR 和 OSR 被认为是治疗 c-AAA 的两种成熟技术。然而,长期比较结果研究不多,人们对修复的耐久性、再次介入的风险和晚期慢性肾功能下降等问题可能会产生担忧。本研究显示,在中位随访>5 年的情况下,两组的总体死亡率和动脉瘤相关死亡率无差异。OSR 后慢性肾功能下降显著升高,而 F-BEVAR 组的再介入率较高。为了获得最佳的长期结局,这两种技术都应在高容量主动脉中心进行,根据患者情况量身定制,并进行适当的监测影像学检查。